Since 1921, heart disease has been the leading cause of death in the United States.
Today, there are about 92.1 million American adults living with some form of cardiovascular disease, which includes heart disease and stroke. The American Heart Association estimates that cardiovascular disease accounts for about one of every three deaths in the United States each year, with someone dying every 40 seconds.
However, these numbers are improving rapidly. Behavioral and lifestyle changes alongside innovative treatments advances. Deaths from heart disease have dropped from 412 (per 100,000 population) in 1980 to just 168 in 2015, and in 2013, after being the third or fourth leading cause of death for 75 years, stroke moved to the fifth spot, according to the Centers for Disease Control and Prevention.
America’s biopharmaceutical researchers are committed to driving continued progress against these devastating conditions, with 200 new medicines in clinical development for cardiovascular disease.